Evolent Health, Inc. reports results for the quarter ended September 30 - Earnings Summary

• Evolent Health, Inc. EVH.N reported quarterly adjusted earnings of 6 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of fifteen analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from -1 cents to 9 cents per share.

• Revenue rose 51.3% to $725.37 million from a year ago; analysts expected $724.19 million.

• Evolent Health, Inc.'s reported EPS for the quarter was a loss of 21 cents​.

• The company reported a quarterly loss of $23.57 million.

• Evolent Health, Inc. shares had risen by 37.5% this quarter and gained 20.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Evolent Health, Inc. is $6.00, about 20% above its last closing price of $4.80

This summary was machine generated from LSEG data November 5 at 07:48 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)